Search

Introduction: Machine learning (ML) algorithms and statistical modeling offer a potential solution to offset the challenge of diagnosing early Alzheimer's disease (AD) by leveraging multiple data sources and combining information on neuropsychological, genetic, and biomarker indicators. Among others, statistical models are a promising tool to enhance the clinical detection of early AD. In the present study, early AD was diagnosed by taking into account characteristics related to whether or not a patient was taking specific drugs and a significant protein as a predictor of Amyloid-Beta (Ab), tau, and ptau [AT(N)] levels among participants. Methods: In this study, the optimization of predictive models for the diagnosis of AD pathologies was carried out using a set of baseline features. The model performance was improved by incorporating additional variables associated with patient drugs and protein biomarkers into the model. The diagnostic group consisted of five categories (cognitively normal, significant subjective memory concern, early mildly cognitively impaired, late mildly cognitively impaired, and AD), resulting in amultinomial classification challenge. In particular, we examined the relationship between AD diagnosis and the use of various drugs (calcium and vitamin D supplements, blood-thinning drugs, cholesterol-lowering drugs, and cognitive drugs). We propose a hybrid-clinical model that runs multiple ML models in parallel and then takes the majority's votes, enhancing the accuracy. We also assessed the significance of three cerebrospinal fluid biomarkers, Ab, tau, and ptau in the diagnosis of AD. We proposed that a hybrid-clinical model be used to simulate the MRI-based data, with five diagnostic groups of individuals, with further refinement that includes preclinical characteristics of the disorder. The proposed design builds a Meta-Model for four different sets of criteria. The set criteria are as follows: to diagnose from baseline features, baseline and drug features, baseline and protein features, and baseline, drug and protein features. Results: We were able to attain a maximum accuracy of 97.60% for baseline and protein data. We observed that the constructedmodel functioned effectively when all five drugs were included and when any single drug was used to diagnose the response variable. Interestingly, the constructed Meta-Model worked well when all three protein biomarkers were included, as well as when a single protein biomarker was utilized to diagnose the response variable. Discussion: It is noteworthy that we aimed to construct a pipeline design that incorporates comprehensive methodologies to detect Alzheimer's over wide-ranging input values and variables in the current study. Thus, the model that we developed could be used by clinicians and medical experts to advance Alzheimer's diagnosis and as a starting point for future research into AD and other neurodegenerative syndromes. [ABSTRACT FROM AUTHOR]

Brain tumors occur due to the expansion of abnormal cell tissues and can be malignant (cancerous) or benign (not cancerous). Numerous factors such as the position, size, and progression rate are considered while detecting and diagnosing brain tumors. Detecting brain tumors in their initial phases is vital for diagnosis where MRI (magnetic resonance imaging) scans play an important role. Over the years, deep learning models have been extensively used for medical image processing. The current study primarily investigates the novel Fine-Tuned Vision Transformer models (FTVTs)--FTVT-b16, FTVT-b32, FTVT-l16, FTVT-l32--for brain tumor classification, while also comparing them with other established deep learning models such as ResNet50, MobileNet-V2, and EfficientNet - B0. A dataset with 7,023 images (MRI scans) categorized into four different classes, namely, glioma, meningioma, pituitary, and no tumor are used for classification. Further, the study presents a comparative analysis of these models including their accuracies and other evaluation metrics including recall, precision, and F1-score across each class. The deep learning models ResNet-50, EfficientNet-B0, and MobileNet-V2 obtained an accuracy of 96.5%, 95.1%, and 94.9%, respectively. Among all the FTVT models, FTVT-l16 model achieved a remarkable accuracy of 98.70% whereas other FTVT models FTVT-b16, FTVTb32, and FTVT-132 achieved an accuracy of 98.09%, 96.87%, 98.62%, respectively, hence proving the efficacy and robustness of FTVT's in medical image processing. [ABSTRACT FROM AUTHOR]

Invasive fungal infections (IFI) pose a significant health burden, leading to high morbidity, mortality, and treatment costs. This study aims to develop and characterize nanomicelles for the codelivery of posaconazole and hemp seed oil for IFI via the oral route. The nanomicelles were prepared using a nanoprecipitation method and optimized through the Box Behnken design. The optimized nanomicelles resulted in satisfactory results for zeta potential, size, PDI, entrapment efficiency, TEM, and stability studies. FTIR and DSC results confirm the compatibility and amorphous state of the prepared nanomicelles. Confocal laser scanning microscopy showed that the optimized nanomicelles penetrated the tissue more deeply (44.9µm) than the suspension (25µm). The drug-loaded nanomicelles exhibited sustained cumulative drug release of 95.48 ± 3.27% for 24 h. The nanomicelles showed significant inhibition against Aspergillus niger and Candida albicans (22.4 ± 0.21 and 32.2 ± 0.46 mm, respectively). The pharmacokinetic study on Wistar rats exhibited a 1.8-fold increase in relative bioavailability for the nanomicelles compared to the suspension. These results confirm their therapeutic efficacy and lay the groundwork for future research and clinical applications, providing a promising synergistic antifungal nanomicelles approach for treating IFIs. [ABSTRACT FROM AUTHOR]

Alzheimer's disease (AD) is a growing public health crisis, a very global health concern, and an irreversible progressive neurodegenerative disorder of the brain for which there is still no cure. Globally, it accounts for 60–80% of dementia cases, thereby raising the need for an accurate and effective early classification. The proposed work used a healthy aging dataset from the USA and focused on three transfer learning approaches: VGG16, VGG19, and Alex Net. This work leveraged how the convolutional model and pooling layers work to improve and reduce overfitting, despite challenges in training the numerical dataset. VGG was preferably chosen as a hidden layer as it has a more diverse, deeper, and simpler architecture with better performance when dealing with larger datasets. It consumes less memory and training time. A comparative analysis was performed using machine learning and neural network algorithm techniques. Performance metrics such as accuracy, error rate, precision, recall, F1 score, sensitivity, specificity, kappa statistics, ROC, and RMSE were experimented with and compared. The accuracy was 100% for VGG16 and VGG19 and 98.20% for Alex Net. The precision was 99.9% for VGG16, 96.6% for VGG19, and 100% for Alex Net; the recall values were 99.9% for all three cases of VGG16, VGG19, and Alex Net; and the sensitivity metric was 96.8% for VGG16, 97.9% for VGG19, and 98.7% for Alex Net, which has outperformed when compared with the existing approaches for the classification of Alzheimer's disease. This research contributes to the advancement of predictive knowledge, leading to future empirical evaluation, experimentation, and testing in the biomedical field. [ABSTRACT FROM AUTHOR]

Maintaining quality in software development projects is becoming very difficult because the complexity of modules in the software is growing exponentially. Software defects are the primary concern, and software defect prediction (SDP) plays a crucial role in detecting faulty modules early and planning effective testing to reduce maintenance costs. However, SDP faces challenges like imbalanced data, high-dimensional features, model overfitting, and outliers. Moreover, traditional SDP models lack transparency and interpretability, which impacts stakeholder confidence in the Software Development Life Cycle (SDLC). We propose SPAM-XAI, a hybrid model integrating novel sampling, feature selection, and eXplainable-AI (XAI) algorithms to address these challenges. The SPAM-XAI model reduces features, optimizes the model, and reduces time and space complexity, enhancing its robustness. The SPAM-XAI model exhibited improved performance after experimenting with the NASA PROMISE repository's datasets. It achieved an accuracy of 98.13% on CM1, 96.00% on PC1, and 98.65% on PC2, surpassing previous state-of-the-art and baseline models with other evaluation matrices enhancement compared to existing methods. The SPAM-XAI model increases transparency and facilitates understanding of the interaction between features and error status, enabling coherent and comprehensible predictions. This enhancement optimizes the decision-making process and enhances the model's trustworthiness in the SDLC. [ABSTRACT FROM AUTHOR]

Together with larger spectroscopic surveys such as the Dark Energy Spectroscopic Instrument (DESI), the precision of large-scale structure studies and thus the constraints on the cosmological parameters are rapidly improving. Therefore, one must build realistic simulations and robust covariance matrices. We build galaxy catalogues by applying a halo occupation distribution (HOD) model upon the FastPM simulations, such that the resulting galaxy clustering reproduces high-resolution N -body simulations. While the resolution and halo finder are different from the reference simulations, we reproduce the reference galaxy two-point clustering measurements – monopole and quadrupole – to a precision required by the DESI Year 1 emission line galaxy sample down to non-linear scales, i.e. |$k\lt 0.5\, h\, \mathrm{Mpc}^{-1}$| or |$s\gt 10\, \mathrm{Mpc}\, h^{-1}$|⁠. Furthermore, we compute covariance matrices based on the resulting FastPM galaxy clustering – monopole and quadrupole. We study for the first time the effect of fitting on Fourier conjugate (e.g. power spectrum) on the covariance matrix of the Fourier counterpart (e.g. correlation function). We estimate the uncertainties of the two parameters of a simple clustering model and observe a maximum variation of 20 per cent for the different covariance matrices. Nevertheless, for most studied scales the scatter is between 2 and 10  per cent. Consequently, using the current pipeline we can precisely reproduce the clustering of N -body simulations and the resulting covariance matrices provide robust uncertainty estimations against HOD fitting scenarios. We expect our methodology will be useful for the coming DESI data analyses and their extension for other studies. [ABSTRACT FROM AUTHOR]